跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9 条关于
“Opakalim”
全部
9
临床试验
0
药物
3
机构
0
资讯
6
3个月前
Biohaven's Opakalim Shows Promise in Epilepsy Trials with Superior Tolerability Profile
23天前
SK Biopharm licenses Biohaven's Kv7 activator Opakalim in $795M deal, targeting 2029 US launch
8天前
FDA Places Partial Clinical Hold on Biohaven's Epilepsy Candidate Opakalim, Pausing New Enrollment in Pivotal Program
10个月前
FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) for Spinocerebellar Ataxia
昨天
SK Biopharmaceuticals Licenses Preclinical LRRK2/c-Abl Dual Inhibitor 1ST-104 for Parkinson's in Deal Worth Up to $314.8M
8天前
FDA Partial Clinical Hold Halts New Enrollment in SK Biopharmaceuticals' Opacalim RISE2 Epilepsy Trial